{"pmid":32298421,"title":"Pandemic Surge Models in the Time of Severe Acute Respiratory Syndrome Coronavirus-2: Wrong or Useful?","text":["Pandemic Surge Models in the Time of Severe Acute Respiratory Syndrome Coronavirus-2: Wrong or Useful?","Ann Intern Med","Wong, John B","32298421"],"journal":"Ann Intern Med","authors":["Wong, John B"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298421","week":"202016|Apr 13 - Apr 19","doi":"10.7326/M20-1956","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651301838849,"score":8.233237,"similar":[{"pmid":32292802,"pmcid":"PMC7138902","title":"Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.","text":["Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.","Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.","Virusdisease","Islam, Arshi","Ahmed, Anwar","Naqvi, Irshad H","Parveen, Shama","32292802"],"abstract":["Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus."],"journal":"Virusdisease","authors":["Islam, Arshi","Ahmed, Anwar","Naqvi, Irshad H","Parveen, Shama"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292802","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s13337-020-00575-1","keywords":["COVID-19","China","Emergence","Global transmission","SARS-CoV-2","Wuhan city"],"source":"PubMed","topics":["Prevention","Transmission","Treatment"],"weight":1,"locations":["Wuhan","Hubei","China","Wuhan","China","Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295567187968,"score":55.95525},{"pmid":32282894,"title":"Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.","text":["Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.","Diagnostic testing to identify persons infected with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction-based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS-CoV-2 infection. Here, the authors review the current array of tests for SARS-CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions.","Ann Intern Med","Cheng, Matthew P","Papenburg, Jesse","Desjardins, Michael","Kanjilal, Sanjat","Quach, Caroline","Libman, Michael","Dittrich, Sabine","Yansouni, Cedric P","32282894"],"abstract":["Diagnostic testing to identify persons infected with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction-based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS-CoV-2 infection. Here, the authors review the current array of tests for SARS-CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions."],"journal":"Ann Intern Med","authors":["Cheng, Matthew P","Papenburg, Jesse","Desjardins, Michael","Kanjilal, Sanjat","Quach, Caroline","Libman, Michael","Dittrich, Sabine","Yansouni, Cedric P"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282894","week":"202016|Apr 13 - Apr 19","doi":"10.7326/M20-1301","source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664182200746115072,"score":50.091972},{"pmid":32220557,"pmcid":"PMC7102517","title":"Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2 Infection.","text":["Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2 Infection.","Severe acute respiratory syndrome coronavirus-2 is still active in Wuhan, China, and is spreading to the rest of the world. Recently, perioperative anesthetic management in patients with suspected or confirmed coronavirus-2 has been reported. However, little has been reported on the anesthetic management of patients undergoing aortic dissection repair in patients with suspected severe acute respiratory syndrome coronavirus-2 infection. During the outbreak in Wuhan, the authors' team completed 4 cases of aortic dissection repair successfully in patients with suspected severe acute respiratory syndrome coronavirus-2 infection. The purpose of the present report is to summarize current knowledge and experiences on anesthetic management in this patient population and to provide clinical practice guidelines on anesthetic management and infection prevention and control in these critically ill patients.","J Cardiothorac Vasc Anesth","He, Hao","Zhao, Shuai","Han, Linlin","Wang, Qi","Xia, Haifa","Huang, Xin","Yao, Shanglong","Huang, Jiapeng","Chen, Xiangdong","32220557"],"abstract":["Severe acute respiratory syndrome coronavirus-2 is still active in Wuhan, China, and is spreading to the rest of the world. Recently, perioperative anesthetic management in patients with suspected or confirmed coronavirus-2 has been reported. However, little has been reported on the anesthetic management of patients undergoing aortic dissection repair in patients with suspected severe acute respiratory syndrome coronavirus-2 infection. During the outbreak in Wuhan, the authors' team completed 4 cases of aortic dissection repair successfully in patients with suspected severe acute respiratory syndrome coronavirus-2 infection. The purpose of the present report is to summarize current knowledge and experiences on anesthetic management in this patient population and to provide clinical practice guidelines on anesthetic management and infection prevention and control in these critically ill patients."],"journal":"J Cardiothorac Vasc Anesth","authors":["He, Hao","Zhao, Shuai","Han, Linlin","Wang, Qi","Xia, Haifa","Huang, Xin","Yao, Shanglong","Huang, Jiapeng","Chen, Xiangdong"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32220557","week":"202014|Mar 30 - Apr 05","doi":"10.1053/j.jvca.2020.03.021","keywords":["COVID-19","SARS-CoV-2","anesthetic management","aortic dissection","infection control"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Case Report"],"weight":1,"_version_":1663352135181402113,"score":45.962357},{"pmid":32271993,"title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","text":["High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","Obesity (Silver Spring)","Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce","32271993"],"journal":"Obesity (Silver Spring)","authors":["Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271993","week":"202015|Apr 06 - Apr 12","doi":"10.1002/oby.22831","keywords":["COVID-19","SRAS-Cov-2","body mass index","intensive care","mechanical ventilation","obesity"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663620083137642498,"score":45.962357},{"pmid":32252141,"title":"Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).","text":["Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).","A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been two novel coronavirus outbreaks in the past two decades. The 2002-2003 outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 death), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 861 people out of a total 2,502 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features.","Clin Exp Pediatr","Park, Su Eun","32252141"],"abstract":["A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been two novel coronavirus outbreaks in the past two decades. The 2002-2003 outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 death), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 861 people out of a total 2,502 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features."],"journal":"Clin Exp Pediatr","authors":["Park, Su Eun"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32252141","week":"202015|Apr 06 - Apr 12","doi":"10.3345/cep.2020.00493","keywords":["COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2","coronavirus"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663352136196423680,"score":44.138947}]}